Abstract
Maintenance of medically induced remission is a clinical challenge in Crohn’s disease (CD), since it is a chronic disease and that often occurs in young people. The introduction of immunosuppressors and biologics has significantly improved the management of these patients, however efficacy and safety of these treatments in the very long term still needs clarification. Furthermore, scientific research is driven more into new drugs to induce remission rather then maintenance.
Keywords: Crohn's disease, maintenance of remission, meta-analysis, Randomized Controlled Trials
Related Journals
Applied Drug Research, Clinical Trials and Regulatory Affairs
21